| Methodological rigor in preclinical cardiovascular studies: targets to enhance reproducibility and promote research translation FD Ramirez, P Motazedian, RG Jung, P Di Santo, ZD MacDonald, ... Circulation research 120 (12), 1916-1926, 2017 | 137 | 2017 |
| Association between plasminogen activator inhibitor-1 and cardiovascular events: a systematic review and meta-analysis RG Jung, P Motazedian, FD Ramirez, T Simard, P Di Santo, S Visintini, ... Thrombosis Journal 16 (1), 12, 2018 | 111 | 2018 |
| Sex bias is increasingly prevalent in preclinical cardiovascular research: implications for translational medicine and health equity for women: a systematic assessment of … FD Ramirez, P Motazedian, RG Jung, P Di Santo, Z MacDonald, T Simard, ... Circulation 135 (6), 625-626, 2017 | 70 | 2017 |
| Role of plasminogen activator inhibitor-1 in coronary pathophysiology RG Jung, T Simard, A Labinaz, FD Ramirez, P Di Santo, P Motazedian, ... Thrombosis research 164, 54-62, 2018 | 43 | 2018 |
| Progenitor cells for arterial repair: incremental advancements towards therapeutic reality T Simard, RG Jung, P Motazedian, P Di Santo, FD Ramirez, JJ Russo, ... Stem cells international 2017, 2017 | 42 | 2017 |
| Evaluation of Plasma Adenosine as a Marker of Cardiovascular Risk: Analytical and Biological Considerations T Simard, R Jung, A Labinaz, MA Faraz, FD Ramirez, P Di Santo, ... Journal of the American Heart Association 8 (15), e012228, 2019 | 28 | 2019 |
| Association Between Self‐Reported Potentially Modifiable Cardiac Risk Factors and Perceived Need to Improve Physical Health: A Population‐Based Study FD Ramirez, Y Chen, P Di Santo, T Simard, P Motazedian, B Hibbert Journal of the American Heart Association 6 (5), e005491, 2017 | 24 | 2017 |
| Female authorship in preclinical cardiovascular research: temporal trends and influence on experimental design A Labinaz, JA Marbach, RG Jung, R Moreland, P Motazedian, P Di Santo, ... JACC: Basic to Translational Science 4 (4), 471-477, 2019 | 23 | 2019 |
| Photoplethysmography using a smartphone application for assessment of ulnar artery patency: a randomized clinical trial P Di Santo, DT Harnett, T Simard, FD Ramirez, A Pourdjabbar, A Yousef, ... CMAJ 190 (13), E380-E388, 2018 | 21 | 2018 |
| Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial P Di Santo, R Mathew, RG Jung, T Simard, S Skanes, B Mao, FD Ramirez, ... Critical Care 25 (1), 289, 2021 | 19 | 2021 |
| Implications of Myocardial Infarction on Management and Outcome in Cardiogenic Shock RG Jung, P Di Santo, R Mathew, O Abdel‐Razek, S Parlow, T Simard, ... Journal of the American Heart Association 10 (21), e021570, 2021 | 18 | 2021 |
| Journal Initiatives to Enhance Preclinical Research: Analyses of Stroke, Nature Medicine, Science Translational Medicine FD Ramirez, RG Jung, P Motazedian, D Perry-Nguyen, P Di Santo, ... Stroke 51 (1), 291-299, 2020 | 16 | 2020 |
| Performance of plasminogen activator inhibitor-1 as a biomarker in patients undergoing coronary angiography: Analytical and biological considerations RG Jung, T Simard, P Di Santo, A Labinaz, R Moreland, AC Duchez, ... Diabetes and Vascular Disease Research 16 (5), 478-482, 2019 | 15 | 2019 |
| Significant valvular dysfunction and outcomes in cardiogenic shock: insights from the randomized DOREMI trial S Parlow, W Weng, P Di Santo, RG Jung, MF Lepage-Ratte, ... Canadian Journal of Cardiology 38 (8), 1211-1219, 2022 | 12 | 2022 |
| Prognostic value of echocardiography-derived right ventricular dysfunction in haemodynamically stable pulmonary embolism: a systematic review and meta-analysis G Prosperi-Porta, P Ronksley, O Kiamanesh, K Solverson, P Motazedian, ... European Respiratory Review 31 (166), 2022 | 10 | 2022 |
| Adenosine as a marker and mediator of cardiovascular homeostasis: a translational perspective T Simard, R Jung, A Labinaz, MA Faraz, FD Ramirez, P Di Santo, I Pitcher, ... Cardiovascular & Haematological Disorders-Drug Targets (Formerly Current …, 2019 | 10 | 2019 |
| Modifiable Risk Factors and Residual Risk Following Coronary Revascularization: Insights From a Regionalized Dedicated Follow-Up Clinic T Simard, RG Jung, P Di Santo, DT Harnett, O Abdel-Razek, FD Ramirez, ... Mayo Clinic Proceedings: Innovations, Quality & Outcomes 5 (6), 1138-1152, 2021 | 9 | 2021 |
| Performance of Plasma Adenosine as a Biomarker for Predicting Cardiovascular Risk T Simard, RG Jung, P Di Santo, FD Ramirez, A Labinaz, C Gaudet, ... Clinical and translational science 14 (1), 354-361, 2021 | 9 | 2021 |
| Methodological Rigor in Preclinical Cardiovascular Research: Contemporary Performance of AHA Scientific Publications RG Jung, C Stotts, D Makwana, P Motazedian, P Di Santo, CY Goh, ... Circulation Research 129 (9), 887-889, 2021 | 8 | 2021 |
| Contrast-free optical coherence tomography: Systematic evaluation of non-contrast media for intravascular assessment T Simard, P Motazedian, K Majeed, K Sarathy, RG Jung, J Feder, ... Plos one 15 (8), e0237588, 2020 | 7 | 2020 |
Trevor SimardInterventional Cardiologist | Structural Heart Disease | Mayo Clinic - RochesterVerified email at mayo.edu
